Wurzen Nutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 2.00 Cr
as on 16-11-2024
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.00 Cr
as on 16-11-2024
- Revenue 53.30%
(FY 2023)
- Profit -27.67%
(FY 2023)
- Ebitda -25.70%
(FY 2023)
- Net Worth 13.04%
(FY 2023)
- Total Assets 2.12%
(FY 2023)
About Wurzen Nutraceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹9.00 Cr.
Tumkur Lokesh, Anuroop Nair, Thirthaprasad Mahadevaiah, and Three other members serve as directors at the Company.
- CIN/LLPIN
U74900KA2016PTC085299
- Company No.
085299
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jan 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Tumkur, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Wurzen Nutraceuticals Private Limited offer?
Wurzen Nutraceuticals Private Limited offers a wide range of products and services, including Ayurvedic Powder and Medicinal Herbs, Herbal Powder, Ayurvedic & Herbal Health Supplement, Herbal Supplements, Ayurvedic & Herbal Extracts, Herbal Extracts.
Who are the key members and board of directors at Wurzen Nutraceuticals?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anuroop Nair  | Director | 18-Jan-2016 | Current |
| Tumkur Lokesh | Director | 18-Jan-2016 | Current |
| Thirthaprasad Mahadevaiah | Director | 18-Jan-2016 | Current |
| Malikayil Aravindakshannair | Director | 18-Jan-2016 | Current |
| Arun Aravind | Director | 18-Jan-2016 | Current |
| Shivanandappa Siddaramaiah | Director | 18-Jan-2016 | Current |
Financial Performance of Wurzen Nutraceuticals.
Wurzen Nutraceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 53.3% increase. The company also saw a substantial fall in profitability, with a 27.67% decrease in profit. The company's net worth Soared by an impressive increase of 13.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wurzen Nutraceuticals?
In 2023, Wurzen Nutraceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nisarga Natural Extracts Private LimitedActive 4 yearsTumkur Lokesh and Shivanandappa Siddaramaiah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 27 Oct 2020 | ₹1.00 Cr | Open |
Canara Bank Creation Date: 17 Apr 2020 | ₹1.00 Cr | Open |
Others Creation Date: 19 Jun 2017 | ₹7.00 Cr | Open |
How Many Employees Work at Wurzen Nutraceuticals?
Unlock and access historical data on people associated with Wurzen Nutraceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wurzen Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wurzen Nutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
